Purespring Therapeutics, a UK-based gene therapy company focused on kidney disease, has raised £80 million ($105 million) in ...

Arda Therapeutics, a biotech focused on targeted cell depletion therapies for chronic diseases, has raised $43 million in a ...

US biotech major Biogen revealed that felzartamab, an investigational anti-CD38 monoclonal antibody, has received ...

US pharma major Bristol Myers Squibb’s recent approval from the US Food and Drug Administration (FDA) for Cobenfy (xanomeline ...

German pharma major Bayer has opened Bayer Co.Lab Shanghai, a new life science incubator in China’s Zhangjiang biopharma ...

Bayer (BAYN: DE) has partnered with MOMA Therapeutics to develop a small molecule oncology program using MOMA’s KNOMATIC ...

Pfizer has reportedly ended its Phase II/III trials for sisunatovir, a promising RSV candidate acquired with ReViral in a ...

The UK has launched the Regulatory Innovation Office (RIO) to reduce regulatory barriers and fast-track approvals for new ...

Cambridge, USA-based City Therapeutics has announced its launch with a vision to lead the future of RNA interference ...

GSK shared new Phase III data on Arexvy, its RSV vaccine, at the 2024 CHEST annual meeting. Results show a single dose of ...

Sage Therapeutics’ share price fell 11% to $6 in pre-market activity on Tuesday, after it announced disappointing top-line ...

Calluna Pharma, a biotech developing treatments for inflammatory and fibrotic diseases, has appointed Mark Gaffney as CEO.